Device
Xeroform
Xeroform is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_1
1
25%
Ph phase_4
2
50%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
Not yet recruiting1
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 31 (25.0%)
Phase 42 (50.0%)
Trials by Status
completed125%
not_yet_recruiting125%
withdrawn125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Pelashield vs Xeroform
NCT07734519
completedphase_3
A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.
NCT05499104
unknownphase_1
Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
NCT04323475
withdrawnphase_4
A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites
NCT02994589
Clinical Trials (4)
Showing 4 of 4 trials
NCT07734519Phase 4
Pelashield vs Xeroform
NCT05499104Phase 3
A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.
NCT04323475Phase 1
Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
NCT02994589Phase 4
A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4